61 results on '"De Ponti F"'
Search Results
2. Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
3. Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators
4. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
5. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems
6. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project
7. Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitors: A Global Analysis of Pharmacovigilance Databases
8. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit
9. Association between the use of proton pump inhibitors and cardiovascular events: A note of caution
10. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
11. Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system
12. Hospitalisations by Drug interactions with nsaids in elderly poly-treated patients: outcome research on administrative databases
13. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies
14. PP016—Exposure to antipsychotics with pro-arrhythmic risk: Combining adverse drug reactions with drug utilization data
15. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons
16. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
17. OC.05.4: MUCOSAL MEDIATORS FROM PATIENTS WITH IRRITABLE BOWEL SYNDROME STIMULATE ENTERIC CHOLINERGIC MOTOR NEURONS IN VITRO VIA PURINERGIC, PROSTAGLANDIN, AND TRPV1 PATHWAYS
18. OC.05.1: COLONIC MUCOSAL NEUROPLASTICITY AND ITS INVOLVEMENT IN SYMPTOM GENERATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
19. Gender- and Age-Related Differences in Muscular and Nerve-Mediated Responses in Human Colon
20. CS.1.1 ALTERED SEROTONIN SIGNALING AND EXTRINSIC SENSORY NEURON ACTIVATION IN IRRITABLE BOWEL SYNDROME
21. OC.10.1 NEUROPLASTIC CHANGES IN THE COLONIC MUCOSA OF PATIENTS WITH IRRITABLE BOWEL SYNDROME
22. 748 EFFECT OF B3-ADRENOCEPTOR MODULATION ON PORTAL PRESSURE IN RATS WITH COMPENSATED CIRRHOSIS
23. Effect of β3-adrenoceptor agonist SR58611A on portal pressure of rats with compensated cirrhosis
24. The β3‐adrenoceptor agonist SR58611A ameliorates experimental colitis in rats
25. P.1.a.007 A genetic assessment of antipsychotic and antidepressant cardiac iatrogenicity: focus on the proarrhythmic profile
26. Publication of a negative trial without disclosing the drug
27. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity
28. Pharmacology of serotonin: what a clinician should know
29. Diagnosis and therapy of irritable bowel syndrome
30. Colonic smooth muscle responses in patients with diverticular disease of the colon: effect of the NK2 receptor antagonist SR48968
31. Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
32. Triptans and gastric accommodation: pharmacological and therapeutic aspects
33. Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders
34. 5-HT4 Receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract
35. 7 PS Type 1 anti-neuronal nuclear antibodies (ANNA-1) induce neuronal apoptosis through APAF-1 and CASPASE-3 activation in SH-SY5Y cells
36. The cathartic colon?
37. Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment
38. Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colon
39. The pharmacological treatment of acute colonic pseudo-obstruction
40. Effects of sumatriptan and rizatriptan on canine gastric compliance and selective blockade by the 5-HT1B/D receptor antagonist GR127935
41. Role of tachykinergic and cholinergic pathways in modulating canine gastric tone and compliance in vivo
42. Correlations between functional changes and different grades of acute rejection in swine small bowel allografts
43. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
44. Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations
45. Peripheral Benzodiazepine Receptor Expression on Leukocytes and Neutrophil Function during Anticonvulsant Monotherapy
46. Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon
47. Small bowel myoelectrical activity after transplantation in pigs: Motility versus ACR score
48. Morphological and functional changes in small-bowel allografts of pigs under combined tacrolimus and mycophenolate mofetil immunosuppression
49. Repeated Administration of SL 84.0418, a New Oral Antihyperglycaemic Agent
50. Characterization of the prokinetic effect of erythromycin on rabbit colonic motility
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.